Bill
HR 961
An honorary House resolution recognizing Sherilyn P. Bell for lab science, public health leadership, and lymphedema advocacy, a symbolic, non-binding acknowledgment.
Status: Resolution adopted
Introduced: February 4, 2025
Final action reported: Adopted (rules suspended), May 15, 2025
Classification: Honorary/commemorative resolution (non‑binding)
Note on metadata: the version content of H.R. 961 provided here is an honorific resolution commending Sherilyn P. Bell. Some header metadata (title referencing “MEMORIAL‑DANIEL A. SALGADO” and an eclectic sponsors list) appears inconsistent with the text of the resolution. This summary is based on the resolution text honoring Sherilyn P. Bell.
Purpose and intent
- The resolution formally commends Sherilyn P. Bell for her professional achievements in laboratory science and public health, and for her advocacy on behalf of patients (notably work on lymphedema coverage).
- It recognizes her leadership, volunteer service, and community contributions and directs the House Clerk to provide an appropriate copy of the resolution to Ms. Bell.
Key provisions and content
- Expresses formal commendation for Sherilyn P. Bell’s career, including:
- Five years in stem cell clinical trials and extensive experience in high‑complexity laboratory testing.
- Leadership roles such as Laboratory Manager at Response Technologies, Inc.; Lead Viral Load Technologist at the Public Health Laboratory (Decatur); and Auditor for Patient Service Centers at Laboratory Corporation of America (LabCorp).
- Highlights advocacy work:
- Active participation with the Lymphedema Advocacy Group and Lighthouse Lymphedema Network.
- Lobbying efforts (including alongside the late Congressman John Lewis and others) that contributed to passage of the U.S. Lymphedema Treatment Act — enacted Dec. 23, 2022 — which closed a Medicare coverage gap for doctor‑prescribed compression garments.
- Notes volunteer and community service:
- Activities with the American Red Cross, New Birth Missionary Baptist Church, Atlanta Day Shelter, cancer support organizations, and outreach to underserved communities.
- Recognizes personal/community affiliations:
- Mother and grandmother, and member of Lambda Epsilon Omega Chapter of Alpha Kappa Alpha Sorority, Inc.
- Administrative instruction:
- Directs the House Clerk to make an appropriate copy of the resolution available to Sherilyn P. Bell.
Who is affected / impact
- Primary effect is honorary: it confers formal recognition and public acknowledgement of Ms. Bell’s contributions.
- No legal, regulatory, or budgetary effects — the resolution is symbolic and non‑binding.
- The recognition may raise public awareness of lymphedema advocacy and related patient‑coverage issues.
Procedural / timeline notes
- Introduced in the House on Feb 4, 2025; referred to committee(s) per the legislative record.
- Reported enrolled and adopted on May 15, 2025 after suspension of the rules.
- Final step: distribution of a copy of the resolution to the honoree as directed.
Bottom line
H.R. 961 is an honorary House resolution that formally recognizes Sherilyn P. Bell’s professional accomplishments in laboratory science and public health, her patient advocacy (notably on lymphedema treatment coverage), and her community service. It is a symbolic commendation with no policy or fiscal effect.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
